Carboplatin is commonly associated with which toxicity?

Unlock all questions

This demo includes only 20 questions. Upgrade to access hundreds of questions, flashcards, exam simulations, and disable ads.

Full question bankExam simulationsFlashcards
From $24.99Unlock all

Prepare for the Neuromuscular Interventions Test with flashcards and multiple-choice questions. Each question includes hints and explanations. Get ready to ace your exam!

Multiple Choice

Carboplatin is commonly associated with which toxicity?

Explanation:
Carboplatin’s most characteristic toxicity is bone marrow suppression, especially thrombocytopenia. This means platelet counts drop more noticeably with carboplatin, increasing the risk of bleeding. While platinum drugs share DNA-crosslinking mechanisms, nephrotoxicity and ototoxicity are more typical with cisplatin, and carboplatin tends to spare the kidneys and inner ear. Peripheral neuropathy can occur but is not as prominent as the platelet suppression. So, thrombocytopenia is the toxicity most commonly associated with carboplatin, guiding the need for regular blood monitoring and potential dose adjustments or supportive care.

Carboplatin’s most characteristic toxicity is bone marrow suppression, especially thrombocytopenia. This means platelet counts drop more noticeably with carboplatin, increasing the risk of bleeding. While platinum drugs share DNA-crosslinking mechanisms, nephrotoxicity and ototoxicity are more typical with cisplatin, and carboplatin tends to spare the kidneys and inner ear. Peripheral neuropathy can occur but is not as prominent as the platelet suppression. So, thrombocytopenia is the toxicity most commonly associated with carboplatin, guiding the need for regular blood monitoring and potential dose adjustments or supportive care.

More Multiple Choice Questions
Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy